Jiangsu Hengrui reported CNY7.05B in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
Cspc Pharmaceutical CNY 4.01B 329.18M Dec/2025
Kangmei Pharma CNY 238.34M 31.95M Mar/2026
Sh Fosun Pharma CNY 5.01B 1.69B Mar/2026
Sh Pharmaceutical CNY 8.09B 639.53M Mar/2026
Sino Biopharmaceutical CNY 10.5B 2.53B Dec/2024
Wuxi Apptec CNY 9.31B 3.04B Jun/2026
Zz Pientze Pharmaceu CNY 1.16B 860.2M Mar/2026